• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用0.3%罗氟司特乳膏治疗顽固性头皮银屑病:一例报告

Treatment of Recalcitrant Scalp Psoriasis with Topical Roflumilast Cream 0.3%: A Case Report.

作者信息

Domingues Erik

机构信息

Dr. Domingues is with Modern Dermatology of Massachusetts in Fall River, Massachusetts and the Department of Dermatology at the University of Massachusetts Chan Medical School in Worcester, Massachusetts.

出版信息

J Clin Aesthet Dermatol. 2025 Jul 1;18(7):24-25.

PMID:40778012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327557/
Abstract

Scalp psoriasis is a chronic immune skin disease affecting up to 80 percent of patients with psoriasis. Treatments include topical steroids, keratolytics, tar, anthralin, vitamin D analogs, and retinoids. However, treatment can be difficult due to the presence of hair. Roflumilast 0.3% cream was approved in 2022 for the treatment of chronic plaque psoriasis, including intertriginous areas. Here, we present the case of a 28-year-old female patient with scalp psoriasis, who had previously trialed both topical and systemic treatments for her disease without success. Use of once daily roflumilast 0.3% cream resulted in rapid scalp psoriasis clearance, with results seen as early as Day 3 and complete clearance by Day 5 of treatment without adverse events or tolerability concerns.

摘要

头皮银屑病是一种慢性免疫性皮肤病,高达80%的银屑病患者会受到影响。治疗方法包括外用类固醇、角质剥脱剂、焦油、蒽林、维生素D类似物和维甲酸。然而,由于有头发,治疗可能会很困难。0.3%的罗氟司特乳膏于2022年获批用于治疗慢性斑块状银屑病,包括间擦部位。在此,我们报告一例28岁头皮银屑病女性患者的病例,该患者此前曾尝试过局部和全身治疗,但均未成功。每天使用一次0.3%的罗氟司特乳膏可使头皮银屑病迅速清除,早在治疗第3天就可见到效果,到治疗第5天完全清除,且无不良事件或耐受性问题。

相似文献

1
Treatment of Recalcitrant Scalp Psoriasis with Topical Roflumilast Cream 0.3%: A Case Report.用0.3%罗氟司特乳膏治疗顽固性头皮银屑病:一例报告
J Clin Aesthet Dermatol. 2025 Jul 1;18(7):24-25.
2
Topical treatments for scalp psoriasis.头皮银屑病的局部治疗
Cochrane Database Syst Rev. 2016 Feb 26;2(2):CD009687. doi: 10.1002/14651858.CD009687.pub2.
3
Topical treatments for chronic plaque psoriasis.慢性斑块状银屑病的局部治疗
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD005028. doi: 10.1002/14651858.CD005028.pub3.
4
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.0.3% 罗氟司特泡沫剂用于头皮和身体银屑病:ARRECTOR 3期随机临床试验
JAMA Dermatol. 2025 May 7. doi: 10.1001/jamadermatol.2025.1136.
5
A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis.外用罗氟司特治疗斑块状银屑病的综述
Ann Pharmacother. 2023 Aug;57(8):966-969. doi: 10.1177/10600280221137750. Epub 2022 Nov 24.
6
Topical anti-inflammatory treatments for eczema: network meta-analysis.外用抗炎治疗湿疹:网状荟萃分析。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2.
7
Severe Relapsing Hailey-Hailey Disease Displaying a Durable Complete Response to Hydroxyurea.严重复发性黑利-黑利病对羟基脲呈现持久完全缓解
Acta Dermatovenerol Croat. 2024 Nov;32(3):168-169.
8
Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp.用于面部或头皮脂溢性皮炎的局部抗炎药。
Cochrane Database Syst Rev. 2014 May 19;2014(5):CD009446. doi: 10.1002/14651858.CD009446.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Treatment of Scalp Psoriasis.头皮银屑病的治疗。
J Drugs Dermatol. 2022 Aug 1;21(8):833-837. doi: 10.36849/JDD.6498.
2
Management of scalp psoriasis: current perspectives.头皮银屑病的管理:当前观点
Psoriasis (Auckl). 2016 Mar 29;6:33-40. doi: 10.2147/PTT.S85330. eCollection 2016.
3
Managing Scalp Psoriasis: An Evidence-Based Review.头皮银屑病的管理:基于证据的综述。
Am J Clin Dermatol. 2017 Feb;18(1):17-43. doi: 10.1007/s40257-016-0222-4.
4
Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes.苯并硼唑磷酸二酯酶抑制剂治疗皮肤炎症:选择性、细胞活性以及对与皮肤炎症和皮肤结构变化相关细胞因子的影响
J Pharmacol Exp Ther. 2016 Sep;358(3):413-22. doi: 10.1124/jpet.116.232819. Epub 2016 Jun 27.